Dr. Dmitrij Hristodorov is a General Partner at Forbion, focusing on life science investments and new company formation. Holding a PhD in immunology from RWTH Aachen University, he leverages his prior experience in R&D and business development at Johnson & Johnson and Bayer to merge scientific insight with venture capital expertise.
He hosts "The Biotech Pulse" podcast, where he interviews biotech founders and executives, exploring topics like translating academic innovation into therapeutic reality, the role of biotech as a discovery engine for pharma, and the challenges of company formation and fundraising.
Before his career in venture capital, he co-invented and published research on novel cytolytic fusion proteins based on human MAP Tau, designed to target and kill cancerous cells.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.